Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Given Consensus Rating of “Hold” by Analysts
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) has been assigned an average rating of “Hold” from the seven analysts that are currently covering the stock, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target […]
More Stories
Low Vitamin D Levels Linked to Slower Healing in Children’s Fractures
By George Citroner Research presented at the American Academy of Pediatrics (AAP) 2024 National Conference & Exhibition underscores the critical...
China Overproducing Lithium to Eliminate Rivals: US Official
By Catherine Yang Jose Fernandez, under secretary for economic growth, energy, and the environment at the U.S. Department of State,...
Appeals Court Lets Ohio Enforce Law Banning Foreign Nationals From Spending on Campaigns
By Zachary Stieber A federal appeals court on Oct. 8 enabled Ohio to enforce a law that bans foreigners from...
US Building Industry Struggling to Fill Available Skilled Worker Positions
By Mark Gilman The nation’s builders not only have to contend with the dilemma of high interest and insurance rates...
Berkshire Hills Bancorp, Inc. (NYSE:BHLB) Receives $26.80 Average Target Price from Analysts
Berkshire Hills Bancorp, Inc. (NYSE:BHLB – Get Free Report) has earned a consensus recommendation of “Hold” from the six brokerages...
Packaging Co. of America (NYSE:PKG) Receives $190.50 Consensus Price Target from Brokerages
Shares of Packaging Co. of America (NYSE:PKG – Get Free Report) have earned an average rating of “Hold” from the...